JP2019526537A5 - - Google Patents

Download PDF

Info

Publication number
JP2019526537A5
JP2019526537A5 JP2019503703A JP2019503703A JP2019526537A5 JP 2019526537 A5 JP2019526537 A5 JP 2019526537A5 JP 2019503703 A JP2019503703 A JP 2019503703A JP 2019503703 A JP2019503703 A JP 2019503703A JP 2019526537 A5 JP2019526537 A5 JP 2019526537A5
Authority
JP
Japan
Prior art keywords
human insulin
zinc complex
acylated derivative
group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019503703A
Other languages
English (en)
Japanese (ja)
Other versions
JP7432361B2 (ja
JP2019526537A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2017/095377 external-priority patent/WO2018024186A1/zh
Publication of JP2019526537A publication Critical patent/JP2019526537A/ja
Publication of JP2019526537A5 publication Critical patent/JP2019526537A5/ja
Priority to JP2022066071A priority Critical patent/JP2022095872A/ja
Application granted granted Critical
Publication of JP7432361B2 publication Critical patent/JP7432361B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019503703A 2016-08-02 2017-08-01 ヒトインスリンまたはそのアナログのアシル化誘導体 Active JP7432361B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022066071A JP2022095872A (ja) 2016-08-02 2022-04-13 ヒトインスリンまたはそのアナログのアシル化誘導体

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201610625257 2016-08-02
CN201610625257.5 2016-08-02
CN201610779132 2016-08-31
CN201610779132.8 2016-08-31
PCT/CN2017/095377 WO2018024186A1 (zh) 2016-08-02 2017-08-01 一种人胰岛素或其类似物的酰化衍生物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022066071A Division JP2022095872A (ja) 2016-08-02 2022-04-13 ヒトインスリンまたはそのアナログのアシル化誘導体

Publications (3)

Publication Number Publication Date
JP2019526537A JP2019526537A (ja) 2019-09-19
JP2019526537A5 true JP2019526537A5 (enExample) 2020-07-02
JP7432361B2 JP7432361B2 (ja) 2024-02-16

Family

ID=61074099

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019503703A Active JP7432361B2 (ja) 2016-08-02 2017-08-01 ヒトインスリンまたはそのアナログのアシル化誘導体
JP2022066071A Pending JP2022095872A (ja) 2016-08-02 2022-04-13 ヒトインスリンまたはそのアナログのアシル化誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022066071A Pending JP2022095872A (ja) 2016-08-02 2022-04-13 ヒトインスリンまたはそのアナログのアシル化誘導体

Country Status (6)

Country Link
US (1) US10815287B2 (enExample)
EP (1) EP3495384A4 (enExample)
JP (2) JP7432361B2 (enExample)
CN (2) CN108463468B (enExample)
TW (1) TWI747929B (enExample)
WO (1) WO2018024186A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3090199A1 (en) * 2018-02-01 2019-08-08 Jiangsu Hengrui Medicine Co., Ltd. Pharmaceutical composition comprising acylated derivative of human insulin analog and preparation method thereof
TW201934752A (zh) 2018-02-09 2019-09-01 大陸商江蘇恆瑞醫藥股份有限公司 一種密碼子優化的人胰島素類似物前體基因和信號肽基因
CA3100869A1 (en) 2018-05-24 2019-11-28 Jiangsu Hengrui Medicine Co., Ltd. Method for preparing precursor of recombinant human insulin or analogue thereof
SG11202106167XA (en) 2018-12-11 2021-07-29 Sanofi Sa Insulin conjugates
BR112022013009A2 (pt) 2019-12-30 2022-09-06 Gan & Lee Pharmaceuticals Co Ltd Derivados de insulina, composição farmacêutica, uso do derivado da insulina e métodos para tratar ou prevenir diabetes, para aumentar a capacidade de um derivado de insulina e para aumentar a potência de um derivado de insulina
TW202229324A (zh) * 2020-11-27 2022-08-01 大陸商江蘇恒瑞醫藥股份有限公司 製備胰島素或其類似物的醯化衍生物的方法
CN112939771A (zh) * 2021-01-28 2021-06-11 宁夏蓝博思化学技术有限公司 长链烷基二酸单叔丁酯的制备方法
EP4347632A4 (en) 2021-05-24 2025-03-26 Sunshine Lake Pharma Co., Ltd. A novel acylated insulin analog
EP4361174A4 (en) 2021-06-25 2025-11-19 Gan & Lee Pharmaceuticals Co Ltd ACYLATED PHARMACEUTICAL COMPOSITION CONTAINING INSULIN
CN118574842A (zh) 2022-01-28 2024-08-30 甘李药业股份有限公司 酰化胰岛素
CN117756914B (zh) * 2023-12-15 2024-09-03 瀚晖制药有限公司 依柯胰岛素的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
EP1132404A3 (en) * 1993-09-17 2002-03-27 Novo Nordisk A/S Acylated insulin
CN1163574A (zh) * 1994-11-17 1997-10-29 伊莱利利公司 酰化的胰岛素类似物
US6310038B1 (en) * 1997-03-20 2001-10-30 Novo Nordisk A/S Pulmonary insulin crystals
WO2003075950A1 (en) * 2002-03-13 2003-09-18 Novo Nordisk A/S Minimising body weight gain in insulin treatment
EP2107069B1 (en) * 2003-08-05 2013-01-16 Novo Nordisk A/S Novel insulin derivatives
ES2402592T3 (es) * 2003-08-05 2013-05-07 Novo Nordisk A/S Nuevos derivados de insulina
PT1969004E (pt) * 2005-12-28 2011-11-25 Novo Nordisk As Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
CN101784563B (zh) * 2007-08-15 2015-02-04 诺沃-诺迪斯克有限公司 具有包括含亚烷基二醇的氨基酸的重复单位的酰基部分的胰岛素
EP2910571B1 (en) * 2008-03-18 2016-10-05 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
US8935928B2 (en) * 2011-10-10 2015-01-20 Lockheed Martin Corporation Integrated air-cycle refrigeration and power generation system
AU2012350586B2 (en) * 2011-12-15 2017-02-02 Jiangsu Hengrui Medicine Co., Ltd. Human insulin analogue and acylated derivative thereof
CN106496322A (zh) * 2015-09-07 2017-03-15 江苏恒瑞医药股份有限公司 人胰岛素或其类似物的酰化衍生物的制备方法
KR20180105236A (ko) * 2016-02-05 2018-09-27 메모리얼 슬로안-케터링 캔서 센터 줄기 세포-유래 외배엽 계통 전구체의 분화 방법

Similar Documents

Publication Publication Date Title
JP2019526537A5 (enExample)
JP2022095872A5 (enExample)
JP2012512901A5 (enExample)
JP2011006428A5 (enExample)
RU99106518A (ru) Glp-1 производные
RU2008143668A (ru) Производное инсулина
WO2011080102A3 (en) Glp-1 analogues and derivatives
CA3084688A1 (fr) Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes
JP2013526501A5 (enExample)
JP2015110654A5 (enExample)
RU2009122582A (ru) Пэг-модифицированный эксендин или аналог эксендина и его композиции и применение
JP2007523881A5 (enExample)
KR970042553A (ko) 캠프토테신 유도체
EP3495384A1 (en) Acylated derivative of human insulin or analogue thereof
RU2008141280A (ru) Агонисты рецептора нейромедина u и их применение
JP2008545793A5 (enExample)
NZ599791A (en) Therapeutic peptides
RU2019109719A (ru) Конъюгаты полимиксин-альгинатных олигомеров
JP2017508741A5 (enExample)
JP2009532384A5 (enExample)
EP3740227A1 (fr) Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide
JP5982562B2 (ja) ペプチドの塩酸塩及び他のペプチドとの併用によるその免疫治療用途
RU2020108281A (ru) Новые ацилированные аналоги инсулина и варианты их применения
RU2019109728A (ru) Конъюгаты бацитрацин-альгинатный олигомер
JP2013516424A (ja) シクロスポリン類似体